CENTER OF MOLECULAR IMMUNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer	28/11/2016	Registered
NGcGM3/VSSP in small cell lung cancer	07/12/2016	Registered outdated
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III.	2010-12-17	Registered
NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II	2010-12-17	Registered
Nimotuzumab cold kit for the immunodiagnosis of solid tumors	05/10/2018	Registered
Nimotuzumab in COVID-19	21/05/2021	Registered
Nimotuzumab in Esophagus premalignant lesions	21/06/2024	Registered
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT)	28/12/2018	Registered outdated
Nimotuzumab in the treatment of patients with acute respiratory difficulty syndrome (ARDS)	03/03/2023	Registered
Nimotuzumab inoperable esophageal epithelial tumors, Phase IV	30/06/2016	Registered
Nimotuzumab-pancreatic cancer-adults-Phase IV.	30/04/2017	Registered
Patients with non small cells lung cancer (NSCLC) and brain metastasis.	2010-12-29	Registered
Phase I/II trial with the mutein no alfa of IL-2	03/02/2017	Registered
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer.	23/05/2014	Registered
Phyisician Led CIMAvax-EGF lung biomarkers	11/03/2021	Registered outdated
Post EUA study of Itolizumab in COVID-19	21/03/2022	Registered outdated
Predictor of response with CIMAvax EGF© in NSCLC Phase III	29/01/2016	Registered
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX	21/05/2021	Registered outdated
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory	09/07/2018	Registered
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer.	26/05/2014	Registered

Registered Trials

Registration process

CENTER OF MOLECULAR IMMUNOLOGY

About the RPCEC

Useful resources